Analyst
Individual Investor
Equibles does not estimate personal net worth.
Bhuvanesh Bhubi is recorded as Analyst at Individual Investor. Bhuvanesh Bhubi has spoken on 1 earnings call across 1 company, most recently for Natco Pharma Limited on November 13, 2026. The companies whose calls Bhuvanesh Bhubi spoke on are classified in the Healthcare sector.
“So I think as of now, Revlimit sales is exhausted. So what's the next big shot drug is in our pipeline?”
Individual Investor
Analyst
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
